Increased body lead burden - Cause or consequence of chronic renal insufficiency?

New England Journal of Medicine

Volumn 348, Issue 4, 2003, Pages 345-347

  Marsden, Philip A ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; BODY BURDEN; CHRONIC KIDNEY FAILURE; COGNITIVE DEFECT; DISEASE ASSOCIATION; DISEASE SEVERITY; EDITORIAL; ENVIRONMENTAL EXPOSURE; LEAD BLOOD LEVEL; LEAD POISONING; LIBIDO DISORDER; LONG TERM EXPOSURE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RISK FACTOR;

CAUSALITY; CHELATION THERAPY; EDETIC ACID; ENVIRONMENTAL EXPOSURE; HUMANS; KIDNEY FAILURE, CHRONIC; LEAD; LEAD POISONING;

EID: 0037461607     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMe020164     Document Type: Editorial

References (14)

1. Jacobs DE, Clickner RP, Zhou JY, et al. The prevalence of lead-based paint hazards in U.S. housing. Environ Health Perspect 2002;110:A599-A606.
2. Lin J-L, Lin-Tan D-T, Hsu K-H, Yu C-C. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes. N Engl J Med 2003;348:277-86.
3. Godwin HA. The biological chemistry of lead. Curr Opin Chem Biol 2001;5:223-7.
4. Fontanellas A, Navarro S, Moran-Jimenez MJ, et al. Erythrocyte aminolevulinate dehydratase activity as a lead marker in patients with chronic renal failure. Am J Kidney Dis 2002;40:43-50.
5. Loghman-Adham M. Aminoaciduria and glycosuria following severe childhood lead poisoning. Pediatr Nephrol 1998;12:218-21.
6. Sanchez-Fructuoso AI, Blanco J, Cano M, et al. Experimental lead nephropathy: treatment with calcium disodium ethylenediaminetetraacetate. Am J Kidney Dis 2002;40:59-67.
7. Staessen JA, Lauwerys RR, Buchet J-P, et al. Impairment of renal function with increasing blood lead concentrations in the general population. N Engl J Med 1992;327:151-6.
8. Payton M, Hu H, Sparrow D, Weiss ST. Low-level lead exposure and renal function in the Normative Aging Study. Am J Epidemiol 1994;140:821-9.
9. Kim R., Rotnitsky A, Sparrow D, Weiss S, Wager C, Hu H. A longitudinal study of low-level lead exposure and impairment of renal function: the Normative Aging Study. JAMA 1996;275:1177-81.
10. Hryhorczuk DO, Rabinowitz MB, Hessi SM, et al. Elimination kinetics ofblood lead in workers with chronic lead intoxication. Am J Ind Med 1985;8:33-42.
11. Lin JL, Ho HH, Yu CC. Chelation therapy for patients with elevated body lead burden and progressive renal insufficiency: a randomized, controlled trial. Ann Intern Med 1999;130:7-13.
12. Sanchez-Fructuoso AI, Prats D, Barrientos A. Treatment of chronic lead intoxication. Ann Intern Med 1999;131:716.
13. Yang T, Wu TN, Hsu SW, Lai CH, Ko KN, Liou SH. Blood lead levels of primary-school children in Penghu County, Taiwan: distribution and influencing factors. Int Arch Occup Environ Health 2002;75:528-34.
14. Kelada SN, Shelton E, Kaufmann RB, Khoury MJ. Delta-aminolevulinic acid dehydratase genotype and lead toxicity: a HuGE review. Am J Epidemiol 2001;154:1-13.